Novartis Investigative Site

Kōriyama, Fukushima 963-8851

0 studies enrolling now · 3 studies all time

What they study most

Cardiovascular Disease, Central Retinal Vein Occlusion, Proliferative Diabetic Retinopathy, Type 2 Diabetes Mellitus

Studies at this site

• Study of Efficacy and Safety of Brolucizumab Versus Panretinal Photocoagulation Laser in Patients With Proliferative Diabetic Retinopathy — Completed
• Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion — Stopped early
• Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases) — Stopped early